On December 10, 2017, the Board of Directors of Minerva Neurosciences, Inc. elected Hans Peter Hasler and William Doyle, as members of the Board, effective immediately. The Board determined that Hasler and Doyle were independent. Hasler and Doyle are expected to stand for re-election at the annual meeting of the stockholders of the company to be held in 2018. Mr. Hasler is Founder and Chief Executive Officer of Vicarius Pharma AG. His prior corporate experience includes Elan Corporation, where he was Chief Operating Officer, and Biogen, Inc., where his positions included Chief Operating Officer, Executive Vice President, Head of Global Neurology and International. Mr. Doyle is Founder of Novocure Ltd., where he has served as Chairman of the Board since 2009 and a director since 2004.